Is Fish Oil Good for Cats With Kidney Disease?

Fish oil shows genuine promise for cats with chronic kidney disease, though the evidence is still emerging and mostly comes from small studies and retrospective analyses rather than large-scale clinical trials. The omega-3 fatty acids in fish oil, particularly EPA and DHA, appear to reduce kidney inflammation, lower protein loss in urine, and may even extend survival time in cats eating kidney-support diets. That said, fish oil is a supplement, not a treatment on its own, and the details matter more than the headline.

What the Research Actually Shows

The most striking piece of evidence comes from a retrospective study that compared survival times in cats with chronic kidney disease fed seven different commercial diets. The diets were similar in composition, with one key exception: the diet highest in eicosapentaenoic acid (EPA, one of the main omega-3s in fish oil) was associated with a median survival of 23 months, while the least effective diet was associated with a median survival of just 12 months.¹ That is a dramatic gap. Because this was a retrospective look rather than a controlled experiment, it is not proof that EPA alone caused the difference. But the consistency of the dietary compositions aside from the EPA content makes it a compelling finding.

A more targeted pilot study examined DHA-enriched fish oil given to cats with polycystic kidney disease, a genetic form of chronic kidney disease common in certain breeds. After supplementation, the cats showed drops in several markers that veterinarians use to track kidney damage: SDMA (a blood marker of kidney function), the urine protein-to-creatinine ratio (which reflects how much protein is leaking through damaged kidneys), and the urinary NAG index (a marker of tubular damage). The fish oil also shifted the cats’ blood fatty acid profiles, increasing DHA levels and improving the ratio of DHA to arachidonic acid, a pro-inflammatory omega-6 fatty acid.² These are early-stage results in a small group, but the direction of the changes is exactly what you would want to see in a kidney-protective supplement.

Why Omega-3s Might Help Failing Kidneys

Chronic kidney disease in cats is not a single event but a slow-burning process driven partly by inflammation and oxidative stress. Research has confirmed that oxidative stress contributes to CKD progression, and that markers of this stress are elevated even in cats with early-stage disease.³ This matters because it means damage is accumulating before clinical signs become obvious, which is when intervention could theoretically do the most good.

The omega-3 fatty acids EPA and DHA compete with arachidonic acid for the same metabolic pathways. When a cat’s diet is rich in omega-3s, there is less arachidonic acid available to produce the inflammatory signaling molecules that accelerate kidney damage. The pilot study in PKD cats demonstrated this directly: DHA supplementation lowered the blood ratio of arachidonic acid while raising DHA levels.² In practical terms, the fish oil was shifting the cat’s internal chemistry away from inflammation and toward a less damaging equilibrium.

Omega-3s also influence blood flow within the kidneys and can help reduce the elevated pressure in the tiny filtering units (glomeruli) that characterizes CKD. Lower glomerular pressure means less protein leaking into the urine, which is one of the changes seen in the pilot study. Protein loss through damaged kidneys is not just a symptom; it actively worsens kidney disease over time, so reducing it has real protective value.

The Bleeding Concern That Turns Out to Be a Non-Issue

One worry that comes up frequently with fish oil, in both human and veterinary medicine, is whether omega-3 supplements thin the blood enough to cause bleeding problems. In cats, this has been tested directly. A study gave healthy cats large doses of purified EPA and DHA daily and measured their bleeding times and platelet aggregation. Despite significant increases in blood levels of both fatty acids, there were no changes in either bleeding time or platelet function.⁴ The researchers concluded that even large doses of fish oil are unlikely to affect clotting in cats. This is reassuring news for anyone considering supplementation in a cat that might need surgery or dental work down the road.

That said, “unlikely to cause problems in healthy cats” and “definitely safe in cats with advanced kidney disease” are not identical statements. Cats with severe CKD sometimes develop anemia and other blood-related complications, and any supplement should be discussed with a veterinarian who knows the individual animal’s full blood work picture. But the bleeding risk specifically seems to be far less of a concern in cats than people often assume.

How Fish Oil Fits Into a Broader Kidney Diet

Fish oil should not be seen as a standalone fix. The survival study that found the EPA connection was comparing complete commercial kidney diets, not fish oil added on top of a regular diet. Kidney diets for cats are formulated with restricted phosphorus, moderate protein, added potassium, and other adjustments that work together. The omega-3 content is one piece of that puzzle, and the survival benefit likely reflects the full dietary package rather than a single ingredient.

This is an important nuance. If your cat is already eating a veterinary kidney diet, it probably contains some fish oil or marine-derived omega-3s. Adding more on top could be beneficial, but it could also push fat intake higher than ideal, especially in a cat that is already struggling with appetite or weight. The goal is to get a good ratio of omega-3 to omega-6 fatty acids in the overall diet, not to dump as much fish oil as possible into the food bowl.

Cats that refuse prescription kidney diets altogether, which is common since many cats are finicky and kidney diets taste different from what they are used to, represent a different scenario. For these cats, adding fish oil to whatever diet they will eat is a reasonable strategy to capture at least some of the anti-inflammatory benefit. Some veterinarians take this approach pragmatically: a cat eating a regular diet supplemented with fish oil is better off than a cat refusing a kidney diet entirely and eating nothing.

Practical Considerations for Supplementing

Not all fish oil products are created equal, and a few things matter when choosing one for a cat with kidney disease:

Form: Liquid fish oil is easier to dose for cats than capsules, and most cats tolerate a small amount mixed into wet food. Some products are flavored for pets, though many cats accept unflavored pharmaceutical-grade human fish oil without complaint.
EPA and DHA content: The two main omega-3s in fish oil have somewhat different roles. EPA is more directly anti-inflammatory, and was the fatty acid highlighted in the survival study. DHA has its own protective effects, as the PKD pilot study demonstrated. A product with both is generally preferred.
Dose: There is no universally agreed-upon dose for cats with CKD. Most veterinary nutritionists recommend somewhere in the range of 30 to 50 mg of combined EPA and DHA per kilogram of body weight daily, but this varies depending on the individual cat’s stage of disease, current diet, and other factors. Your veterinarian can help dial in the right amount.
Freshness: Fish oil oxidizes over time, turning rancid. Rancid oil may actually promote the oxidative stress you are trying to reduce. Store it in the refrigerator after opening, use it within a reasonable timeframe, and sniff it occasionally. If it smells strongly fishy or off, replace it.

Cod liver oil, which many people have on hand, is not a good substitute. It contains vitamins A and D at levels that can be toxic to cats if given regularly. Standard fish oil or marine-sourced omega-3 oil is the safer choice.

Algal Oil as an Alternative

Fish oil is not the only way to get omega-3 fatty acids into a cat’s diet. Algal oil, derived from microalgae that are the original source of the omega-3s that fish accumulate through their diet, has been tested as an alternative. Research comparing algal oil and fish oil in cat food found that serum DHA rose at similar rates with both sources. The bioavailability of EPA and DHA from algal oil appeared comparable to fish oil, though the researchers noted that the algal product would need to deliver equivalent concentrations to match the biological effects of a given fish oil.⁵

Algal oil may appeal to owners concerned about heavy metal contamination in fish-derived products, or about the environmental sustainability of marine-sourced oils. Some algal products are richer in DHA than EPA, which is worth noting if your veterinarian specifically wants a higher EPA supplement. But as a delivery vehicle for omega-3 fatty acids in general, algal oil appears to work just as well in cats.

When To Start and When To Be Cautious

Timing is worth thinking about. The finding that oxidative stress markers are already elevated in cats with stage 1 CKD suggests that the inflammatory damage driving kidney decline starts early, well before a cat shows obvious signs of illness.³ The DHA pilot study also focused on early-stage disease and found improvements in kidney markers at that point.² This fits the general principle that interventions aimed at slowing kidney disease tend to be most effective when started earlier rather than later. A cat diagnosed at IRIS stage 2 likely has more to gain from omega-3 supplementation than a cat already in stage 4 with severe kidney failure, though supplementation may still help reduce inflammation at any stage.

There are situations where caution is warranted. Cats with pancreatitis or other conditions that make fat digestion difficult may not tolerate fish oil well. Cats on certain medications, particularly some immunosuppressants, might have interactions worth discussing with a veterinarian. And as mentioned, cats in late-stage CKD with significant complications like severe anemia or gastrointestinal problems have a more complex clinical picture where the risks and benefits need to be weighed individually.

One more practical point: cats with kidney disease often have poor appetites, and the strong smell of fish oil can either help or hurt. Some cats find it appealing and will eat food they would otherwise ignore once fish oil is added. Others are put off by it. If your cat falls into the second camp, starting with a very small amount and gradually increasing, or switching to a less pungent algal oil, can sometimes solve the problem.

What the Science Still Needs to Settle

The evidence for fish oil in feline CKD is encouraging but genuinely limited. The survival study was retrospective and compared whole diets, not isolated supplements. The DHA pilot study was small and focused on a single genetic form of kidney disease. There are no large, randomized, placebo-controlled trials specifically testing fish oil supplementation in cats with naturally occurring CKD of all types. This is not unusual in veterinary medicine, where funding for large clinical trials is scarce, but it means the strength of the evidence does not yet match the enthusiasm many veterinarians and cat owners have for fish oil.

The mechanistic rationale is strong: omega-3s reduce inflammation, inflammation drives kidney disease progression, and the early pilot data in cats lines up with what has been seen in human nephrology and in rodent models. But strong rationale and small pilot studies do not always translate into confirmed clinical benefits at the population level. It is reasonable to supplement a CKD cat with fish oil based on what we know today. It is also reasonable to expect that future research will refine the picture, possibly identifying which cats benefit most, which omega-3 ratios are ideal, and at what stages of disease supplementation makes the biggest difference.

For now, fish oil occupies a sensible middle ground: low risk, plausible benefit, and enough real data to make it a reasonable addition to a comprehensive kidney disease management plan. Most veterinary internists already include it in their CKD protocols. The unanswered questions are about optimization, not about whether it belongs in the toolkit at all.